Optimized BEAC conditioning regimen improves clinical outcomes of autologous hematopoietic stem cell transplantation in non-Hodgkin lymphomas
International Journal of Hematology · 2024
DOI: 10.1007/s12185-024-03755-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Hematology, 2024. Verfasst von Sha Zhou und 11 weiteren Autor:innen. Beteiligte Einrichtung: Medical Center of Hematology, Xinqiao Hospital of Army Medical University, State Key Laboratory of Trauma and Chemical Poisoning, Chongqing Key Labor…. Hauptthemen laut MEDLINE: Transplantation Conditioning, Hematopoietic Stem Cell Transplantation, Lymphoma, Non-Hodgkin, Cyclophosphamide. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Translational Research Grant of NCRCH, Natural Science Foundation of Chongqing Innovation Group Science Program.
Abstract (Originalsprache)
The conditioning regimen is an important part of autologous hematopoietic stem cell transplantation (ASCT). We explored the efficacy and safety of an optimized BEAC (adjusted-dose, intermediate-dose cytarabine and reduced-dose cyclophosphamide, AD-BEAC) conditioning regimen for non-Hodgkin lymphoma (NHL). A total of 141 NHL patients received AD-BEAC or a standard-dose BEAC (SD-BEAC) conditioning regimen from January 2007 to December 2017, and 104 patients were included in the study after 1:1 propensity matching. The 5-year overall survival (OS) and progression free survival (PFS) rates were significantly higher with AD-BEAC than with SD-BEAC (82.7% vs. 67.3%, P = 0.039; 76.9% vs. 57.7%, P = 0.039). Transplant-related mortality (TRM) was 3.8% in both the AD-BEAC and SD-BEAC groups. The AD-BEAC group had lower incidence of oral ulcers and cardiotoxicity than the SD-BEAC group. An optimized BEAC conditioning regimen is an effective conditioning regimen for ASCT in NHL with acceptable toxicity, that is more effective and safer than a standard BEAC conditioning regimen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Center of Hematology, Xinqiao Hospital of Army Medical University, State Key Laboratory of Trauma and Chemical Poisoning, Chongqing Key Laboratory of Hematology and Microenvironment, Chongqing, China.
- National Clinical Research Center for Hematologic Diseases, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
- Department of Epidemiology, Army Medical University, Chongqing, China.
- Medical Center of Hematology, Xinqiao Hospital of Army Medical University, State Key Laboratory of Trauma and Chemical Poisoning, Chongqing Key Laboratory of Hematology and Microenvironment, Chongqing, China. zhangxxi@s…
- National Clinical Research Center for Hematologic Diseases, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China. zhangxxi@sina.com.
- Medical Center of Hematology, Xinqiao Hospital of Army Medical University, State Key Laboratory of Trauma and Chemical Poisoning, Chongqing Key Laboratory of Hematology and Microenvironment, Chongqing, China. gaotiantia…
Förderung
- National Natural Science Foundation of China
- Translational Research Grant of NCRCH
- Natural Science Foundation of Chongqing Innovation Group Science Program
- Chongqing Science and Health Joint Medical Research Major Project
- Military Clinical Medical Innovation Project of Xinqiao hospital
Zitieren
APA
Zhou, S., Rao, J., Ma, X., Zeng, Y., Xiang, X., Li, J., Liu, H., Lin, S., Dong, S., Li, F., Zhang, X., & Gao, L. (2024). Optimized BEAC conditioning regimen improves clinical outcomes of autologous hematopoietic stem cell transplantation in non-Hodgkin lymphomas. International Journal of Hematology. https://doi.org/10.1007/s12185-024-03755-7
Vancouver
Zhou S, Rao J, Ma X, Zeng Y, Xiang X, Li J, et al. Optimized BEAC conditioning regimen improves clinical outcomes of autologous hematopoietic stem cell transplantation in non-Hodgkin lymphomas. International Journal of Hematology. 2024. doi:10.1007/s12185-024-03755-7
BibTeX
@article{Zhou2024,
author = {Zhou, Sha and Rao, Jun and Ma, Xiangyu and Zeng, Yunjing and Xiang, Xixi and Li, Jiali and Liu, Hongyun and Lin, Shijia and Dong, Song and Li, Fu and Zhang, Xi and Gao, Li},
title = {Optimized BEAC conditioning regimen improves clinical outcomes of autologous hematopoietic stem cell transplantation in non-Hodgkin lymphomas},
journal = {International Journal of Hematology},
year = {2024},
doi = {10.1007/s12185-024-03755-7}
}
EUVIMED